Helicobacter Pylori Test Market

Market Definition

Global Helicobacter Pylori Test market size is valued at USD 479.3 million in 2025 and projected to grow at a CAGR of 6.1% during the forecast period, reaching USD 769.7 million by 2033.

Helicobacter pylori is a bacteria that infect the digestive system. H. pylori can cause peptic ulcers. Helicobacter pylori tests help to detect a Helicobacter pylori infection in the stomach and upper part of the small intestine. Helicobacter pylori tests are done through endoscopic and non-endoscopic procedures.

Market Dynamics

Rising prevalence of helicobacter pylori is a key driving factor of the market. Helicobacter pylori is the cause of peptic ulcers and can also cause gastritis and stomach cancer. H. pylori affect approximately 50% of the world's population. Around 30% to 40% of people in the United States get H. pylori infection. In the United States, the estimated prevalence is 20% for people younger than 30 years and 50% for people older than 60 years. H. pylori prevalence is higher in Hispanics, African Americans, and the elderly. H. pylori prevalence in Hispanics is 60%, more than 54% in African Americans, and 20% in whites. Further, the presence of poor sanitation, poor personal hygiene, contaminated water or food, and high dense population are the factors expecting the market growth over the period. However, lack of awareness regarding helicobacter pylori infection in underdeveloped countries might hamper market growth. Lack of knowledge regarding H. pylori bacterium modes of transmission, associated diseases, carcinogenic effect and means of prevention, and lack of awareness on the transmission routes of H. pylori infection. Moreover, growing demand for point of care testing devices for helicobacter pylori would provide lucrative opportunities for the market in the coming years.

Market Segmentation

The global helicobacter pylori test market is mainly classified based on type, technology, and end user. Type is further segmented into Endoscopic and Non-Endoscopic. By technology, the market is divided into Point-of-Care (POC), Immunoassays, and Molecular Diagnostics. By end user, the market is further divided into Hospital & Clinics, Diagnostic Center, and Others.

Based on technology, Point-of-Care (POC) was dominating the global helicobacter pylori test market in 2019, owing to the rising investment in R&D processes to gain competitive advantage and offer distinguished solutions, and commercialization of Point-of-Care (POC) technology for helicobacter pylori testing. For instance, Exalenz Bioscience has introduced the new BreathID Hp Lab system. The BreathID Hp systems are intuitive and time-efficient products that detect active carcinogenic H. pylori bacterial infection. The point-of-care BreathID Hp Lab system provides an automated solution for batch test analysis.

Regional Analysis

Based on geography, the global helicobacter pylori test market is divided into North America, Europe, Asia-Pacific, South America, and Middle East & Africa. North America is further divided in the U.S., Canada, and Mexico, whereas Europe consists of the UK, Germany, France, Italy, and Rest of Europe. Asia-Pacific is segmented into India, China, Japan, South Korea, and Rest of Asia-Pacific. The South America region includes Brazil, Argentina, and the Rest of South America, while the Middle East & Africa is categorized into GCC Countries, Egypt, South Africa, and Rest of Middle East & Africa.

Europe has shown significant growth in 2019, due to the commercialization of new technology for helicobacter pylori testing, the partnership between companies to develop helicobacter pylori testing device, and government organizations are taking initiatives to create awareness in public regarding H. Pylori infection. For instance, the Healthy Stomach Initiative (HSI) has conducted an awareness program to boost research about gastroenteritis, functional dyspepsia and gastric cancer. The awareness program was conducted to improve early detection, prevent its development, and extend survival. The development of gastric carcinogenesis is due to the infection with bacterium Helicobacter pylori. At least 90% of gastric cancer cases are related to H. pylori. The government body has several data showing that helicobacter pylori testing helps in early detection of gastric cancer.

Competitive landscape

Key players operating in the helicobacter pylori test industry include Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Cardinal Health, Bio-Rad Laboratories, Inc., QIAGEN, Quest Diagnostics Incorporated, Meridian Bioscience, CorisBioconcept SPRL, and Biohit Oyj.

Increasing research studies on Helicobacter pylori test by the companies, rising awareness about helicobacter pylori test by the companies to increase their competitiveness in the market, the collaboration between companies to develop and market helicobacter pylori test, and commercialization of new helicobacter pylori test are some of the strategies adopted by the major companies. For instance, on August 21, 2018, TECHLAB, Inc., developer and manufacturer of rapid non-invasive diagnostic tests for gastrointestinal diseases, has received U.S. Food and Drug Administration (FDA) approval for the H. PYLORI QUIK CHEK and H. PYLORI CHEK tests. These tests are designed to aid in the diagnosis of H. pylori infection. The H. PYLORI QUIK CHEK test is a rapid diagnostic test that helps to detect H. pylori in 30 minutes. The H. PYLORI CHEK test is a 96-well plate format diagnostic for laboratories testing large numbers of specimens in one hour. 

Helicobacter Pylori Test Market Key Segments:

By Type

• Endoscopic
• Non-Endoscopic

By Technology

• Point-of-Care (POC)
• Immunoassays
• Molecular Diagnostics

By End User

• Hospital & Clinics
• Diagnostic Center
• Others

Key Global Helicobacter Pylori Test Industry Players

• Hoffmann-La Roche Ltd
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• Cardinal Health
• Bio-Rad Laboratories, Inc.
• QIAGEN
• Quest Diagnostics Incorporated
• Meridian Bioscience
• CorisBioconcept SPRL
• Biohit Oyj

Report Attributes	Details
Study Period	2021-2033
Base Year	2025
Estimated Year	2026
Forecast Period	2026-2033
Historical Period	2021-2025
Growth Rate	CAGR 6.1% from 2026 to 2033
Revenue Unit	USD million
Sales Volume Unit	Units
Segmentation	By Technology, By Type, End User, , and Region
By Region	North America (By Technology, By Type, End User, , and Country) United States Canada Mexico
	Europe (By Technology, By Type, End User, , and Country) Germany France UK Italy Spain Russia Rest of the Europe
	Asia Pacific (By Technology, By Type, End User, , and Country) China Japan India South Korea Australia Southeast Asia Rest of Asia Pacific
	South America (By Technology, By Type, End User, , and Country) Brazil Argentina Rest of South America
	Middle East and Africa (By Technology, By Type, End User, , and Country) Saudi Arabia UAE South Africa Rest of Middle East and Africa

What Report Provides

• Key Company Market Share, Revenue, and Position/Ranking
• Key Market Leaders
• Full In-Depth Analysis of the Parent Industry
• Industry Statistics
• Important Changes in Market and Its Dynamics
• Segmentation Details of the Market
• Historical, On-Going, and Projected Market Analysis
• Assessment of Niche Industry Developments
• Market Share Analysis
• Key Strategies of Major Players
• Company Profiles of Key Players
• Unique Selling Prepositions of Leading Market Players
• Emerging Segments and Regional Growth Potential
• Key Strategic Recommendations
• Competitive Benchmarking
• Import Export Trade Statistics